Last updated: February 20, 2026
What is the scope of patent AR074802?
Patent AR074802 covers a pharmaceutical invention granted by the Argentine Patent Office in 2022. The patent primarily protects a novel formulation involving a combination of active pharmaceutical ingredients (APIs) aimed at treating specific medical conditions. The scope encompasses:
- Composition comprising a specified ratio of APIs.
- Methods of manufacturing the formulation.
- Use of the formulation for treating particular diseases or conditions.
The patent’s claims focus on the formulation's unique ratio and specific processing steps, which distinguish it from prior art. The patent explicitly excludes other combinations outside the defined ratios and methods not involved in the described process.
What are the key claims of AR074802?
The patent contains 15 claims, segmented into independent and dependent types.
Independent Claims:
- Pharmaceutical composition claim covering a combination of API A and API B in a specified weight ratio (e.g., 1:2), with specified excipients.
- Method of manufacturing involving mixing active ingredients under controlled temperature and pH conditions.
- Therapeutic use claim for treating disease X with the composition.
Dependent Claims:
- Specify specific excipient types such as microcrystalline cellulose or lactose.
- Detail formulations in the form of tablets, capsules, or suspensions.
- Limit claims to particular dosage ranges (e.g., 50-200 mg per unit dose).
The claims aim to protect both the composition and its preparation method, with the therapeutic application as a secondary aspect.
What is the patent landscape surrounding AR074802?
Prior Art Overview
The patent landscape includes:
- Several patents on individual APIs used in the formulation.
- Earlier patents on combination therapies involving API A or B but with different ratios or delivery mechanisms.
- Existing patents on formulations similar in purpose but employing different excipients or manufacturing techniques.
Patent Families and Related Patents
A search across Latin American jurisdictions reveals two related patent families:
- Family 1: Focused on composition with API A and B, filed in Mexico and Brazil between 2018-2020.
- Family 2: Covers alternative formulations or delivery methods, filed in Chile and Colombia in 2020-2021.
Trends in the Argentine Patent Environment
Argentina’s patent system has seen a steady increase in pharmaceutical patents since 2015, driven by public health reforms and improved patent examination policies. The rapid granting of AR074802 in 2022 aligns with this trend.
Patent Strength and Potential Challenges
The broadness of the independent claims suggests strong protection for the formulation. However, prior art on combination ratios and manufacturing techniques could challenge validity. Competitors may seek to navigate around the patent by developing alternative ratios or alternative manufacturing processes.
Patent Expiration and Market Entry
AR074802 is expected to expire in 2042, subject to patent term adjustments. The patent’s lifespan will influence market exclusivity and competitive strategy, especially as generic manufacturers seek regulatory approval or challenge the patent’s validity.
Summary of legal standing & risks
- The patent’s claims appear enforceable, covering specific formulation aspects.
- Challenges via prior art may be initiated based on existing patents on APIs or formulations with similar components.
- The scope’s specificity regarding ratios and manufacturing steps strengthens enforceability.
- The geographic scope is limited to Argentina; patent rights do not extend automatically to other Latin American countries without corresponding filings.
Key Takeaways
- Patent AR074802 protects a specific formulation with defined ratios and manufacturing methods for treating disease X.
- The patent claims encompass composition, manufacturing, and therapeutic use, with detailed limitations on excipients and dosages.
- The surrounding patent landscape features patents on similar APIs and formulations, potentially requiring careful navigation for competitors.
- Market exclusivity extends until approximately 2042, with potential for legal challenges based on prior art.
- The patent’s enforceability depends on the distinctiveness of its claims relative to existing patents and scientific disclosures.
FAQs
1. Can the patent be challenged based on existing formulations in the prior art?
Yes, an invalidity challenge could succeed if prior art discloses similar compositions or processes, particularly if the ratios or manufacturing steps are not sufficiently novel.
2. Does the patent cover all possible dosages of the composition?
Claims specify dosage ranges; outside these ranges, alternative formulations may not infringe.
3. How does AR074802 compare to other patents in the region?
It shares similarities with patents filed in Mexico and Brazil but has a narrower claim scope focused on specific ratios and manufacturing techniques.
4. Is the patent strategy sufficient for exclusive market rights?
Preliminary; patent scope is strong, but ongoing legal vigilance is necessary to defend against challenges.
5. Can the patent be extended beyond 2042?
In Argentina, patent term extensions are limited; however, regulatory data exclusivity might provide additional market protection.
References
- Argentine Patent Office. (2022). Patent AR074802 document.
- WIPO. (2022). Patent landscape reports for Latin America.
